Rezolute (RZLT) Depreciation and Depletion (2014 - 2019)
Rezolute's (RZLT) quarterly Depreciation and Depletion came in at $3000.0 in Q3 2019, down 88.0% year-on-year from $25000.0 in Q3 2018, and down 88.0% quarter-over-quarter from $25000.0 in Q3 2018.
Rezolute (RZLT) Depreciation and Depletion (2014 - 2019) Analysis & Trends
Rezolute has disclosed Depreciation and Depletion across 6 years of filings, most recently posting $3000.0 for Q3 2019.
- Depreciation and Depletion for Q3 2019 came in at $3000.0, down 88.0% year-over-year; the trailing twelve-month figure through Sep 2019 was $594607.0 (down 30.73% YoY), and the FY2025 annual result was $31000.0, down 13.89% from the prior year.
- Depreciation and Depletion came in at $3000.0 for Q3 2019 at Rezolute, down from $25000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $299826.0 in Q2 2018 to a low of $3000.0 in Q3 2019.
- The 5-year median for Depreciation and Depletion is $266697.0 (2017), against an average of $190612.8.
- Across the five-year window, Depreciation and Depletion soared 674.33% in 2016 and plunged 90.62% in 2018, its largest moves.
- Rezolute's Depreciation and Depletion stood at $150225.0 in 2015, then jumped by 85.11% to $278074.0 in 2016, then decreased by 4.06% to $266781.0 in 2017, then tumbled by 90.63% to $25000.0 in 2018, then tumbled by 88.0% to $3000.0 in 2019.
- The last three Depreciation and Depletion figures came in at $3000.0 (Q3 2019), $25000.0 (Q3 2018), and $299826.0 (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Rezolute | 415.38 Mn | 415.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 3,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Jun 30, 2018 | 299,826.00 |
| Jun 30, 2018 | 299,826.00 |
| Mar 31, 2018 | 266,781.00 |
| Mar 31, 2018 | 266,781.00 |
| Dec 31, 2017 | 266,781.00 |
| Dec 31, 2017 | 266,781.00 |
| Sep 30, 2017 | 266,613.00 |
| Sep 30, 2017 | 266,613.00 |
| Jun 30, 2017 | 277,620.00 |
| Jun 30, 2017 | 277,620.00 |
| Mar 31, 2017 | 282,829.00 |
| Mar 31, 2017 | 282,829.00 |
| Dec 31, 2016 | 278,074.00 |
| Dec 31, 2016 | 278,074.00 |
| Sep 30, 2016 | 268,355.00 |
| Sep 30, 2016 | 268,355.00 |